Company / Capital Expenditures
Cytosorbents Corp Capital Expenditures History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$672.0K
FY2018
5-year range
$153.2K / $990.7K
FY2014-FY2018
Trend
-32.2%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 8 years, ranging from $19,850 in FY2013 to $990,673 in FY2017.
Based on SEC 10-K filings.
$671,970 in FY2018 with a 5-year CAGR of +102.3%.
Improved from $153,157 to $671,970 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- +102.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +102.3%, indicating consistent growth.
- In FY2018, capital expenditures decreased 32.2% year-over-year.
- Peak capital expenditures was recorded in FY2017.
- Lowest capital expenditures in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $672.0K | -32.2% |
| FY2017 | $990.7K | +546.8% |
| FY2016 | $153.2K | -62.1% |
| FY2015 | $403.6K | +163.5% |
| FY2014 | $153.2K | +671.6% |
| FY2013 | $19.9K | +0.0% |
| FY2012 | $19.9K | -42.7% |
| FY2011 | $34.7K | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026